Search Results - "Terao, Toshiki"

Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment by Terao, Toshiki, Minami, Yosuke

“…The Hedgehog (Hh) pathway, containing the Patched (PTCH) and Smoothened (SMO) multitransmembrane proteins, is the main regulator of vertebrate embryonic…”
Get full text

Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study by Matsunami, Masatoshi, Suzuki, Tomo, Terao, Toshiki, Kuji, Hiroshi, Matsue, Kosei

Get full text

A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling by Abe, Yoshiaki, Sakata-Yanagimoto, Mamiko, Fujisawa, Manabu, Miyoshi, Hiroaki, Suehara, Yasuhito, Hattori, Keiichiro, Kusakabe, Manabu, Sakamoto, Tatsuhiro, Nishikii, Hidekazu, Nguyen, Tran B., Owada, Yohei, Enomoto, Tsuyoshi, Sawa, Aya, Bando, Hiroko, Yoshida, Chikashi, Tabata, Rikako, Terao, Toshiki, Nakayama, Masahiro, Ohshima, Koichi, Usuki, Kensuke, Oda, Tatsuya, Matsue, Kosei, Chiba, Shigeru

“…The activities of non-haematopoietic cells (NHCs), including mesenchymal stromal cells and endothelial cells, in lymphomas are reported to underlie…”
Get full text

Osteosclerotic myeloma without features of POEMS syndrome by Terao, Toshiki, Matsue, Kosei

Get full text

Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation by Tsushima, Takafumi, Terao, Toshiki, Narita, Kentaro, Fukumoto, Ami, Ikeda, Daisuke, Kamura, Yuya, Kuzume, Ayumi, Tabata, Rikako, Miura, Daisuke, Takeuchi, Masami, Matsue, Kosei

“…We evaluated anti-spike protein antibody (anti-S) production in 130 hematopoietic stem cell transplant (HSCT) recipients who received the coronavirus…”
Get full text

Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA–1273 vaccine: A case report by Kamura, Yuya, Terao, Toshiki, Akao, Satoshi, Kono, Yumi, Honma, Koichi, Matsue, Kosei

“…•The patient developed leg pain and livedo reticularis after mRNA-1273 vaccination.•His blood creatine kinase level was markedly elevated and MRI showed…”
Get full text

Total diffusion volume in MRI vs. total lesion glycolysis in PET/CT for tumor volume evaluation of multiple myeloma by Terao, Toshiki, Machida, Youichi, Narita, Kentaro, Kuzume, Ayumi, Tabata, Rikako, Tsushima, Takafumi, Miura, Daisuke, Takeuchi, Masami, Tateishi, Ukihide, Matsue, Kosei

“…Objective This study compared the tumor burden and prognostic impact of total diffusion volume (tDV) and total lesion glycolysis (TLG) in the same patients…”
Get full text

Multiple myeloma with t(11;14)‐associated immature phenotype has lower CD38 expression and higher BCL2 dependence by Kitadate, Akihiro, Terao, Toshiki, Narita, Kentaro, Ikeda, Sho, Takahashi, Yuto, Tsushima, Takafumi, Miura, Daisuke, Takeuchi, Masami, Takahashi, Naoto, Matsue, Kosei

“…CD38 expression on myeloma cells is a critical factor affecting the early response to the anti‐CD38 antibody daratumumab. However, factors affecting CD38…”
Get full text

Antibody response to COVID-19 vaccination in patients with lymphoma by Narita, Kentaro, Nakaji, So, Tabata, Rikako, Terao, Toshiki, Kuzume, Ayumi, Tsushima, Takafumi, Ikeda, Daisuke, Fukumoto, Ami, Miura, Daisuke, Takeuchi, Masami, Doi, Masahiro, Umezawa, Yuka, Otsuka, Yoshihito, Takamatsu, Hiroyuki, Matsue, Kosei

“…Patients with lymphoma are at increased risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); therefore, evaluation of SARS-CoV-2 vaccination…”
Get full text

Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma by Terao, Toshiki, Machida, Youichi, Tateishi, Ukihide, Tsushima, Takafumi, Narita, Kentaro, Ikeda, Daisuke, Fukumoto, Ami, Kuzume, Ayumi, Tabata, Rikako, Miura, Daisuke, Takeuchi, Masami, Matsue, Kosei

“…This study investigated the clinical significance of loss of spleen visualization (LSV) on whole-body diffusion-weighted imaging (WB-DWI) in patients with…”
Get full text

Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria by Narita, Kentaro, Miura, Daisuke, Tsushima, Takafumi, Terao, Toshiki, Kuzume, Ayumi, Tabata, Rikako, Takeuchi, Masami, Matsue, Kosei

“…Stringent complete response (sCR) is defined as a deeper response than complete response (CR) in multiple myeloma. Whether achieving sCR correlates with better…”
Get full text

Increasing chemisorbed silane coupling agents in surface‐treated layer of silica particles by Nakamura, Takashi, Tsutsumi, Ryota, Hashiguchi, Chisato, Terao, Toshiki, Manabe, Kei, Hirai, Tomoyasu, Fujii, Syuji, Nakamura, Yoshinobu

“…In the surface treated inorganic particles with silane coupling agent (SCA), chemisorbed and physisorbed molecules are present in the treated layer. Increasing…”
Get full text

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma by Terao, Toshiki, Yamashita, Takeshi, Fukumoto, Ami, Kamura, Yuya, Ikeda, Daisuke, Kuzume, Ayumi, Tabata, Rikako, Tsushima, Takafumi, Miura, Daisuke, Narita, Kentaro, Takeuchi, Masami, Doi, Masahiro, Umezawa, Yuka, Otsuka, Yoshihito, Takamatsu, Hiroyuki, Matsue, Kosei

“…We conducted a prospective, three-center, observational study in Japan to evaluate the prevalence of seropositivity and clinically protective titer after…”
Get full text

EBV-PTLD in a patient after haploidentical stem-cell transplantation with post-transplant cyclophosphamide by Terao, Toshiki, Tsushima, Takafumi, Fukumoto, Ami, Kuzume, Ayumi, Miura, Daisuke, Narita, Kentaro, Takeuchi, Masami, Matsue, Kosei

“…Here, we describe the case of a male patient with Epstein-Barr virus post-transplantation lymphoproliferative disorder (EBV-PTLD), which developed 18 months…”
Get full text

Evaluation of the safety and efficacy of daratumumab outside of clinical trials by Kobayashi, Hiroki, Tsushima, Takafumi, Terao, Toshiki, Abe, Yoshiaki, Miura, Daisuke, Narita, Kentaro, Kitadate, Akihiro, Takeuchi, Masami, Matsue, Kosei

“…Daratumumab-based therapy has been shown to have significant clinical efficacy in phase 3 trials of patients with relapse or refractory multiple myeloma…”
Get full text

Anionic Polymerization of Methacrylate-functionalized Ionic Monomers in Ionic Liquid by Otozawa, Nobuyuki, Yoshioka, Masataka, Ihara, Daiki, Hamajima, Rio, Kato, Raito, Terao, Toshiki, Fukuma, Hiroto, Kuretani, Satoshi, Seko, Tamio, Fujii, Syuji, Nakamura, Yoshinobu, Kobayashi, Motoyasu, Takahara, Atsushi, Hirai, Tomoyasu

“…Anionic polymerization of methacrylate-functionalized ionic monomers, 2-(methacryloyloxy)ethyltrimethylammonium chloride (MTAC) and…”
Get full text

Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases by Fukumoto, Ami, Terao, Toshiki, Kuzume, Ayumi, Tabata, Rikako, Tsushima, Takafumi, Miura, Daisuke, Ikeda, Daisuke, Kamura, Yuya, Narita, Kentaro, Takeuchi, Masami, Matsue, Kosei

“…Chylous effusion is associated with lymphatic obstruction or leakage in mediastinal or abdominal lymph nodes, and is a rare but troublesome complication in…”
Get full text

Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease by Matsunami, Masatoshi, Suzuki, Tomo, Fukuda, Junko, Terao, Toshiki, Ukai, Kohei, Sugihara, Shinnosuke, Toishi, Takumi, Nagaoka, Kanako, Nakata, Mayumi, Ohara, Mamiko, Yashima, Jun, Kuji, Hiroshi, Matsue, Kosei

“…Currently, it is unclear whether the progression of chronic kidney disease (CKD) could be an independent predictor of antibody response after administration of…”
Get full text

Light chain deposition disease involving kidney and liver in a patient with IgD myeloma by Tsushima, Takafumi, Suzuki, Tomo, Terao, Toshiki, Miura, Daisuke, Narita, Kentaro, Takeuchi, Masami, Shimuzu, Akira, Matsue, Kosei

“…IgD multiple myeloma (MM) is a rare subtype of MM and light chain deposition disease (LCDD) outside the kidney is also a rare and has scarcely been reported…”
Get full text

Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft- Versus -Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant Cyclophosphamide by Terao, Toshiki, Matsuoka, Ken-Ichi, Narita, Kentaro, Tsushima, Takafumi, Yuyama, Satoshi, Kuzume, Ayumi, Tabata, Rikako, Miura, Daisuke, Takeuchi, Masami, Matsue, Kosei

“…The prevention of chronic graft- -host disease (cGVHD) is important for recipients of hematopoietic stem-cell transplantation (HSCT). As one of the etiologies,…”
Get full text